-
Mashup Score: 1
March 31 2023Combined long-term survival results from nonrandomized phase II trial NRG Oncology RTOG 0630 and the ancillary analysis of the combined NRG-RTOG 0630/9514 trials indicate that pathologic complete response (pCR) is associated with improved survival outcomes for patients with localized soft tissue sarcoma (STS) who receive preoperative chemoradiotherapy or radiotherapy. This data…
Source: NRGCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 5
February 03 2023NRG Oncology Phase III clinical trial, NRG-GY018, evaluating pembrolizumab in combination with standard of care chemotherapy (carboplatin and paclitaxel) met its primary endpoint of progression free survival (PFS) for the treatment of patients with stage III-IV or recurrent endometrial carcinoma, regardless of mismatch repair status. A pre-specified interim analysis, conducted by…
Source: NRGCategories: Hem/Oncs, Latest HeadlinesTweet-
The beat goes on for pembrolizumab now with activity in endometrial cancer, regardless of mismatch repair status. https://t.co/6qR5MTpE6x
-
-
Mashup Score: 0NRG Oncology Announces New Veterans Affairs and Military Treatment Facility Subcommittee, Appoints Subcommittee Chairs - 2 year(s) ago
April 11 2022NRG Oncology, a National Cancer Institute (NCI) National Clinical Trials Network (NCTN) group focused on improving outcomes for adults with cancer through international clinical research, recently created a Veterans Affairs/Military Treatment Facility (VA-MTF) Subcommittee to provide a forum for advocating for these communities and engaging them in NRG…
Source: NRGCategories: Latest Headlines, OtolaryngologyTweet-
Congratulations Dr. Vlad Sandualche! https://t.co/IaVj6rowPW
-
-
Mashup Score: 0NRG Oncology Announces New Veterans Affairs and Military Treatment Facility Subcommittee, Appoints Subcommittee Chairs - 2 year(s) ago
April 11 2022NRG Oncology, a National Cancer Institute (NCI) National Clinical Trials Network (NCTN) group focused on improving outcomes for adults with cancer through international clinical research, recently created a Veterans Affairs/Military Treatment Facility (VA-MTF) Subcommittee to provide a forum for advocating for these communities and engaging them in NRG…
Source: NRGCategories: Latest Headlines, OtolaryngologyTweet-
“NRG Oncology is increasing efforts to improve access for Veterans and Service Members to state of the art clinical trials.” https://t.co/qL0FoGvoN1
-
-
Mashup Score: 0The University of Michigan T32 in Cancer Care Delivery Accepts First Cohort of Pre- and Post- Doctoral Scholars - 3 year(s) ago
November 11 2021The University of Michigan T32 in Cancer Care Delivery Research (CCDR), funded by the National Cancer Institute, accepted its first cohort of pre- and post- doctoral scholars in 2020. Trainees are focused on identifying patterns and consequences of cancer care delivery, improving patient-centered and system-level outcomes in cancer, and optimizing cancer care delivery…
Source: NRGCategories: Hem/Oncs, Latest HeadlinesTweet-
We greatly appreciate our partnership with @NRGonc to build capacity for cancer care delivery research. https://t.co/qiymwwSkwg
-
-
Mashup Score: 2Congratulations to the NRG Oncology NCORP Members Assigned to NCI Steering Committees - 3 year(s) ago
October 12 2021The following NRG Oncology National Cancer Institute (NCI) Community Oncology Research Program (NCORP) members have recently been appointed to NCI Steering Committees.David T. Marshall, MD, MSDr. Marshall was recently appointed to serve as the Community Oncologist on the NCI Genitourinary Cancer Steering Committee (GUSC). As a part of the NCI GUSC, he will participate on…
Source: NRGCategories: Hem/Oncs, Latest HeadlinesTweet-
RT @NRGonc: Congratulations to the NRG Oncology NCORP Members Assigned to NCI Steering Committees https://t.co/mVBSMcOI78 https://t.co/cLSH…
-
-
Mashup Score: 10Dr. Yom Appointed Head and Neck Cancer Committee Chair - 3 year(s) ago
August 27 2021PHILADELPHIA, PA – NRG Oncology, a National Cancer Institute (NCI) National Clinical Trials Network (NCTN) group focused on improving outcomes for adults with cancer through international clinical research, recently appointed a new Committee Chair to the organization’s Head and Neck Cancer Committee (HNCC). Sue S. Yom, MD, PhD, MAS, FASTRO will be assuming the role of NRG HNCC…
Source: NRGCategories: Latest Headlines, Oncologists2Tweet-
RT @NRGonc: Dr. Sue Yom @UCSFHospitals appointed new NRG Oncology Head & Neck Cancer Committee chair. Read more: https://t.co/wHnyxlcXef ht…
-
-
Mashup Score: 1Outstanding NRG Researcher to Receive 2021 PA Breast Cancer Coalition Potamkin Prize - 3 year(s) ago
August 13 2021NRG Newsletter Article from the PA Breast Cancer CoalitionNRG Oncology Breast Cancer Researcher Sandra Swain, MD, FACP, FASCO will be awarded the 2021 Potamkin Prize as announced by NRG Oncology Patient Advocate Committee Co-Chair and President of the PA Breast Cancer Coalition Pat Halpin-Murphy. Dr. Swain is a world-renowned researcher and oncologist at Georgetown University…
Source: NRGCategories: Hem/Oncs, Latest HeadlinesTweet-
RT @NRGonc: Outstanding NRG Oncology Researcher to Receive 2021 PA Breast Cancer Coalition Potamkin Prize https://t.co/qLvjQk2Xun @PBCC @Sa…
-
-
Mashup Score: 2NRG Oncology Health Equity New Investigator Mentor Program f - 3 year(s) ago
January 20 2021NRG Meeting Program Announcement: January 20, 2021 Applications Due: March 31, 2021 at email: fielde@nrgoncology.orgFunding to begin: June 2021 for two yearsMentee and Mentor funding for two years ($15,000 and $5,000 per year as a stipend)Applications for Pilot funding for a project is a separate process with potentially $50,000 for a CCDR, CPC or Health…
Source: NRGCategories: Healthcare Professionals, Latest HeadlinesTweet-
RT @ErinGillespieMD: 🎉Awesome opportunity 💫from @NRGonc!! #radonc #DEandI 👉link to more info: https://t.co/cxzWucZBJm Apps due March 31,…
-
-
Mashup Score: 12020 In Review: A Message from the Chairs of NRG Oncology’s - 3 year(s) ago
January 12 2021Despite the challenges experienced in 2020, we are happy to report that the NRG Protocol Development Department coordinated the activation of 12 studies: 11 through CTEP and 1 through DCP (See table). The exciting news is that we have another 13 NCI-approved concepts that are in protocol development with activations anticipated in 2021 and 2022. There are 22 other concepts that…
Source: NRGCategories: Hem/Oncs, Latest HeadlinesTweet-
https://t.co/nKCZIHYArp @NRGonc 12 new studies opened and 22 in the pipeline: even in the middle of the pandemic @NRGonc investigators are continuing the fight against cancer @NCICancerTrials https://t.co/qwb6HSQmxm
-
Congratulations dianwang84 @RushCancer @RushMedical #sarcoma @NRGonc @JAMAOnc https://t.co/Z7FZt5bPVp